On this instalment of Wellbeing, Guy Murphy speaks with Professor Michael Breakspear about his research involving the emerging role of AI in wellbeing and healthcare, specifically his recent paper, "Transforming mental health research and care through artificial intelligence".

On this instalment of Wellbeing, Guy Murphy speaks with Professor Michael Breakspear about his research involving the emerging role of AI in wellbeing and healthcare, specifically his recent paper, "Transforming mental health research and care through artificial intelligence".

Wellbeing

Wellbeing is a podcast and nationally distributed radio show that is heard across dozens of community radio stations all over Australia. It is provided via the Community Broadcasting Association.

The show delves into the most pressing topics around mental and physical health, talking with leading experts in their fields and those with lived experience. The show is hosted by Guy Murphy, Jack Hodgins, Oliver Croft, and Graham Wilson.

Wellbeing is a podcast and nationally distributed radio show that is heard across dozens of community radio stations all over Australia. It is provided via the <a href="https://www.cbaa.org.au/">Community Broadcasting Association</a>.
The show delves into the most pressing topics around mental and physical health, talking with leading experts in their fields and those with lived experience. The show is hosted by Guy Murphy, Jack Hodgins, Oliver Croft, and Graham Wilson.

In this episode of Wellbeing, Professor Michael Breakspear discusses the emerging role of artificial intelligence in mental health and wellbeing. He explores how AI can support research, improve understanding of brain and mental health conditions, and enhance clinical care when used responsibly alongside human oversight. The conversation also considers both the opportunities and limitations of AI in healthcare, including the importance of ethical safeguards, transparency, and ensuring technology complements rather than replaces human judgement.

Professor Michael Breakspear - AI and Wellbeing

GLP-1 receptor agonists have become some of the most talked-about medications in recent years. You may have heard names such as liraglutide, semaglutide (Ozempic and Wegovy), and tirzepatide (Mounjaro). These treatments have attracted attention because they can significantly reduce appetite and support weight loss while also helping to manage blood glucose levels.

The breakthrough came when researchers developed long-acting versions of hormones naturally released by the body after eating, including GLP-1 and, in some cases, GIP. These hormones help regulate hunger and promote feelings of fullness. While the body's natural response lasts only a short time, modern medications extend these effects for up to a week with a single injection.

Since results from major clinical trials emerged in the early 2020s, GLP-1 therapies have transformed obesity treatment, delivering weight-loss outcomes that surpass those achieved by previous medications and offering new hope for people struggling with weight management.

- Laureate Professor Clare Collins, internationally distinguished leader in nutrition and dietetics, University of Newcastle

GLP-1 receptor agonists have become some of the most talked-about medications in recent years. You may have heard names such as&nbsp;liraglutide, semaglutide (Ozempic and Wegovy), and tirzepatide (Mounjaro). These treatments have attracted attention because they can significantly reduce appetite and support weight loss while also helping to manage blood glucose levels.
The breakthrough came when researchers developed long-acting versions of hormones naturally released by the body after eating, including GLP-1 and, in some cases, GIP. These hormones help regulate hunger and promote feelings of fullness. While the body's natural response lasts only a short time, modern medications extend these effects for up to a week with a single injection.
Since results from major clinical trials emerged in the early 2020s, GLP-1 therapies have transformed obesity treatment, delivering weight-loss outcomes that surpass those achieved by previous medications and offering new hope for people struggling with weight management.
- Laureate Professor Clare Collins, internationally distinguished leader in nutrition and dietetics, University of Newcastle

The Weight-Loss Revolution: Professor Clare Collins Explains Ozempic, Wegovy, Mounjaro and the Science Behind GLP‑1 Medications

Professor Clare Collins - The weight-loss revolution: understanding GLP-1 medications

This week on Wellbeing, we welcome Renée McDonald, counsellor, psychotherapist, coach and spiritual mentor. With more than 20 years’ experience helping people navigate life’s challenges, Renée shares her insights on spirituality, personal growth, resilience and finding meaning in a busy world. We explore the connection between emotional wellbeing and spiritual wellbeing, how to reconnect with your authentic self, and practical ways to cultivate balance, purpose and inner peace. Whether you're seeking greater clarity, healing or direction in life, this thoughtful conversation offers inspiration, wisdom and tools to support your wellbeing journey.

This week on Wellbeing, we welcome Ren&eacute;e McDonald, counsellor, psychotherapist, coach and spiritual mentor. With more than 20 years&rsquo; experience helping people navigate life&rsquo;s challenges, Ren&eacute;e shares her insights on spirituality, personal growth, resilience and finding meaning in a busy world. We explore the connection between emotional wellbeing and spiritual wellbeing, how to reconnect with your authentic self, and practical ways to cultivate balance, purpose and inner peace. Whether you're seeking greater clarity, healing or direction in life, this thoughtful conversation offers inspiration, wisdom and tools to support your wellbeing journey.

Renée McDonald - Spirituality and Wellbeing

On this edition, Guy Murphy speaks with University of Newcastle alumni and medical director of Sleep Medicine, Dr Antonio Ambrogetti, about factors influencing sleep quality, hygiene, and disorders. 

On this edition, Guy Murphy speaks with University of Newcastle alumni and medical director of Sleep Medicine, Dr Antonio Ambrogetti, about factors influencing sleep quality, hygiene, and disorders.&nbsp;

Professor Michael Breakspear - AI and Wellbeing

In 1 playlist(s)

Wellbeing

Social links

Follow podcast

Recent clips